Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng
Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng

Hong Kong public hospitals to revise Covid-19 treatment guidelines, highlight effective drugs behind low mortality rates

  • Hospital Authority’s infectious disease expert says new guidelines will highlight Interferon as major medication, combined with Ribavirin
  • Revelation comes as city continues to register drop in new daily cases amid third wave

Topic |   Coronavirus pandemic
Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng
Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng
READ FULL ARTICLE